This finding was supported by GEPIA (Gene Expression Profiling Interactive Analysis) (Li et al., 2021), which showed that AKR1C1 was significantly higher in NSCLC (Figure 3B). This evidence concerns the gene AKR1C1 and non-small cell lung carcinoma.